23 hrs ago
TriVascular Technologies, Inc. Announces Full Exercise of Underwriters' Option
SANTA ROSA, Calif., April 17, 2014 -- TriVascular Technologies, Inc. , manufacturer of the Ovation Prime Abdominal Stent Graft System, today announced the full exercise of the option granted to the underwriters to purchase an additional 975,000 shares of its common stock at a public offering price of $12.00 per share in connection with its ... (more)
Trending on the Topix Network
Platinum strike widens global deficit
A labour dispute that all but shut platinum mines in South Africa since January is extending the longest shortfall in global production since 2005, which Morgan Stanley predicts will take at least four years to fix.
Wed Apr 16, 2014
Vital Therapies Prices Initial Public Offering at $12 per Share
Vital Therapies, Inc. , a biotherapeutic company developing a cell-based therapy targeting the treatment of acute liver failure, today announced the pricing of its initial public offering of 4,500,000 shares of common stock at a price to the public of $12.00 per share.
Finance and Commerce
Builders began fewer homes than forecast in March
The pace of U.S. home construction rebounded less than forecast in March, held back by declines in warmer parts of the country that indicate the recovery in residential building will be slow to develop.
Credit Suisse rejects FX claims after internal investigation
Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.
The Washington Post
Credit Suisse Net Falls 34% on Lower Investment Bank Profit
Credit Suisse Group AG, the second- biggest Swiss bank, said first-quarter profit fell 34 percent as earnings at the investment bank dropped.
Credit Suisse Profit Fell 34 % on Lower Investment Bank Earnings
Credit Suisse Group AG , the second-biggest Swiss bank, said first-quarter profit fell 34 percent as earnings at the investment bank dropped.
Tue Apr 15, 2014
Adamas Pharmaceuticals Announces Closing of Its Initial Public Offering
Adamas Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced the closing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $16.00 per share.
Will An Ongoing Investigation Over Possible Tax Evasion Hurt Credit Suisse (CS) Stock?
The Department of Financial Services, which regulates the New York bank office of the Swiss bank, has specifically requested the employment records of Roger Schaerer, former head of the New York branch, the paper said.
Behrman Capital completes $570 mln recap of Pelican Products
Behrman Capital, a private equity investment firm based in New York and San Francisco, announced today that it has completed a $570 million recapitalization for Pelican Products, Inc., the global leader in the design and manufacture of high-performance protective case solutions and advanced portable lighting systems.
Mon Apr 14, 2014
Credit Suisse poaches Lazard banker to head Americas financial services
Credit Suisse AG has hired Jim Spencer from Lazard Ltd as head of financial institutions investment banking for the Americas, according to an internal memo seen by Reuters on Monday.
Sun Apr 13, 2014
The New Zealand Herald
Earnings, data to dominate Wall St
Overall the start of the quarterly earnings season was positive but with investors nervous about the outlook, it only took JPMorgan's disappointing quarter, released on Friday, to dent sentiment.
Fri Apr 11, 2014
Chinese online cosmetics retailer Jumei files for $400 million U.S. IPO
Jumei International Holding Ltd, backed by venture-capital firm Sequoia Capital, filed with U.S. regulators on Friday to raise up to $400 million in an initial public offering of American Depositary Shares.
UPDATE 1-China's cross-market trading could make A-Shares ETFs a good buy -analysts
U.S. investors could benefit from China's decision to allow cross-market investing between Shanghai and Hong Kong by buying exchange-traded funds that have access to China's mainland A-shares market, Credit Suisse analysts said in a note on Friday.
Initial public offerings scheduled to debut next week
The following is a list of initial public offerings planned for the coming week.
Wed Apr 09, 2014
Adamas Pharmaceuticals Announces Pricing Of Its Initial Public Offering
Adamas Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions.
Sydney Morning Herald
need2know: Stocks set to surge higher
Official labour force figures to be released on Thursday are expected to show the number of people with jobs fell by 5000 in March, an AAP survey of 11 economists shows, after a surprise rise of 47,300 in February.
Tue Apr 08, 2014
N.Y. Said to Probe Credit Suisse Role in Tax Shelters
Why Clients Need Help With Family Governance Many clients don't know this area of expertise exists, but they know they need help with it, says Paul Pagnato, whose Pagnato-Karp Group works with UHNW families.
Mon Apr 07, 2014
RAIT Financial Trust Prices Public Offering of Unsecured Senior Notes Due 2024
RAIT granted the underwriters a 30-day option to purchase up to an additional $9.0 million aggregate principal amount of the Notes in the offering to cover over-allotments.
Financial Stocks: Financial stocks fall ahead of earnings
Financial stocks fell with the broader market on Monday, ahead of the start of earnings season, as analysts revised down earning expectations.